Clinical Trials Market Research Report by Design, Phase, Indication, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19- Product Image

Sale

Clinical Trials Market Research Report by Design, Phase, Indication, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Report
229 Pages
October 2022
Region: Global
360iResearch™
ID: 5134269

UP TO €1968EUR$1,990USD£1,697GBP OFF until Dec 31^st 2022

The Global Clinical Trials Market size was estimated at USD 32.27 billion in 2021, USD 35.14 billion in 2022, and is projected to grow at a CAGR of 9.05% to reach USD 54.30 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Design, the market was studied across Interventional Study and Observational Study. The Interventional Study is further studied across Adaptive Clinical Trial, Non-randomized Control Trial, and Randomized Control Trial. The Observational Study is further studied across Case Control Study, Cohort Study, Cross Sectional Study, and Ecological Study.
Based on Phase, the market was studied across Phase I, Phase II, Phase III, and Phase IV.
Based on Indication, the market was studied across Autoimmune/Inflammation, Cardiovascular, CNS condition, Diabetes, Infectious Diseases, Obesity, Oncology, and Pain management.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trials market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Market, including Accell Clinical Research, LLC, Atlant Clinical Ltd., Charles River Laboratories International, Inc., Clinipace, Eli Lilly and Company, Icon PLC, IQVIA Holdings, Inc., Novo Nordisk A/S, Parexel International Corporation, Pfizer Inc., ProPharma Group Holdings, LLC, SGS S.A., SIRO Clinpharm Private Limited, Syneos Health, Inc., Thermo Fisher Scientific Inc., and Wuxi AppTec Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trials Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Market?
6. What is the market share of the leading vendors in the Global Clinical Trials Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trials Market?

Frequently Asked Questions about the Global Clinical Trials Market

What is the estimated value of the Global Clinical Trials Market?

The Global Clinical Trials Market was estimated to be valued at $32.27 Billion in 2021.

What is the growth rate of the Global Clinical Trials Market?

The growth rate of the Global Clinical Trials Market is 9.0%, with an estimated value of $54.3 Billion by 2027.

What is the forecasted size of the Global Clinical Trials Market?

The Global Clinical Trials Market is estimated to be worth $54.3 Billion by 2027.

Who are the key companies in the Global Clinical Trials Market?

Key companies in the Global Clinical Trials Market include Accell Clinical Research, LLC, Atlant Clinical Ltd., Charles River Laboratories International, Inc., Clinipace, Eli Lilly and Company, Icon PLC, IQVIA Holdings, Inc., Novo Nordisk A/S and Pfizer Inc..

Report Attribute	Details
No. of Pages	229
Published	October 2022
Forecast Period	2021 - 2027
Estimated Market Value ( USD ) in 2021	USD 32.27 Billion
Forecasted Market Value ( USD ) by 2027	USD 54.3 Billion
Compound Annual Growth Rate	9.0%
Regions Covered	Global
No. of Companies Mentioned	16

FIGURE 1. GLOBAL CLINICAL TRIALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL TRIALS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL CLINICAL TRIALS MARKET DYNAMICS
FIGURE 11. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY DESIGN, 2027
FIGURE 14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDY, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ADAPTIVE CLINICAL TRIAL, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIALS MARKET SIZE, BY NON-RANDOMIZED CONTROL TRIAL, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROL TRIAL, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CASE CONTROL STUDY, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL TRIALS MARKET SIZE, BY COHORT STUDY, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CROSS SECTIONAL STUDY, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ECOLOGICAL STUDY, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2021 VS 2027 (%)
FIGURE 24. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY PHASE, 2027
FIGURE 26. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE IV, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 31. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2027
FIGURE 33. GLOBAL CLINICAL TRIALS MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CNS CONDITION, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DIABETES, 2018-2027 (USD MILLION)
FIGURE 37. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBESITY, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2027 (USD MILLION)
FIGURE 41. AMERICAS CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. AMERICAS CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 43. AMERICAS CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 44. AMERICAS CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 45. ARGENTINA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. BRAZIL CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. CANADA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. MEXICO CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 51. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 52. UNITED STATES CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 53. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 55. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 56. ASIA-PACIFIC CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 57. AUSTRALIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. CHINA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. INDIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. INDONESIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. JAPAN CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. MALAYSIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. PHILIPPINES CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. SINGAPORE CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. TAIWAN CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. THAILAND CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. VIETNAM CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 73. DENMARK CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. EGYPT CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. FINLAND CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. FRANCE CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. GERMANY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. ISRAEL CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. ITALY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. NETHERLANDS CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. NIGERIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. NORWAY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. POLAND CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. QATAR CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. RUSSIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. SPAIN CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. SWEDEN CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. SWITZERLAND CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. TURKEY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. GLOBAL CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 95. GLOBAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 96. GLOBAL CLINICAL TRIALS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021